Ann: Increased Scheme Consideration from Pfizer, page-278

Did you ever see that guy walking a tightrope between the twin towers? That's Tony Keating. This balancing act must be a tremendous psychological burden on him and I imagine he feels terribly alone. I doubt he ever imagined he would have to assume a role akin to that of a double agent. I don't know if you will read this Dr Keating but for what it's worth I trust you. I do not think you want ResApp sold and so not only will I be voting no, but I assure you I will never vote yes. With this much blue sky potential, the logic is that if this company is worth buying then it can't be worth selling.